Ensysce Biosciences, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

ENSC

organization

SIC: 2834

SEC Insider

$14.9M

72 transactions

Summary

Ensysce Biosciences, Inc. (ENSC) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $10.8MSales: —22 insiders

Date	Insider	Type	Value
2022-12-09	GOWER BOB G	Buy	$500K
2023-03-01	GOWER BOB G	Buy	$130K
2023-02-28	GOWER BOB G	Buy	$54K
2023-03-02	GOWER BOB G	Buy	$44K
2022-05-25	Kirkpatrick Lynn(Chief Executive Officer)	Buy	$34K
2022-05-26	Kirkpatrick Lynn(Chief Executive Officer)	Buy	$14K
2022-12-09	GOWER BOB G	A	—
2022-06-23	Levin Adam	A	—
2022-06-23	Benton Andrew	A	—
2022-06-23	Rosebraugh Curtis	A	—
2022-06-23	GOWER BOB G	A	—
2022-06-23	Rauch Lee M.	A	—
2022-06-23	Martin Steven Robert	A	—
2022-06-23	Chang William H	A	—
2022-02-17	Kirkpatrick Lynn(Chief Executive Officer)	A	—
2022-02-17	Birkett Kevin Geoffrey(Chief Commercial Officer)	A	—
2022-02-17	Humphrey David Carl(Chief Financial Officer)	A	—
2022-02-17	Kirkpatrick Lynn(Chief Executive Officer)	A	—
2022-02-04	Humphrey David Carl(Chief Financial Officer)	A	—
2022-02-04	Pestano Linda(Chief Development Officer)	A	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Ensysce Biosciences, Inc. — Contributions, Lobbying & Contracts | Poliscope